Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs PIRAMAL ENTERPRISES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES PIRAMAL ENTERPRISES ALKEM LABORATORIES/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 33.2 -28.3 - View Chart
P/BV x 4.3 0.6 746.0% View Chart
Dividend Yield % 1.1 3.8 28.4%  

Financials

 ALKEM LABORATORIES   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
PIRAMAL ENTERPRISES
Mar-22
ALKEM LABORATORIES/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs4,0683,013 135.0%   
Low Rs2,6711,612 165.7%   
Sales per share (Unadj.) Rs889.4586.3 151.7%  
Earnings per share (Unadj.) Rs140.556.4 249.2%  
Cash flow per share (Unadj.) Rs166.084.3 196.9%  
Dividends per share (Unadj.) Rs34.0033.00 103.0%  
Avg Dividend yield %1.01.4 70.7%  
Book value per share (Unadj.) Rs722.41,487.0 48.6%  
Shares outstanding (eoy) m119.57238.66 50.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.83.9 96.1%   
Avg P/E ratio x24.041.0 58.5%  
P/CF ratio (eoy) x20.327.4 74.0%  
Price / Book Value ratio x4.71.6 299.9%  
Dividend payout %24.258.5 41.3%   
Avg Mkt Cap Rs m402,868551,910 73.0%   
No. of employees `000NANA-   
Total wages/salary Rs m19,62721,350 91.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,342139,933 76.0%  
Other income Rs m1,6277,201 22.6%   
Total revenues Rs m107,968147,134 73.4%   
Gross profit Rs m20,38062,822 32.4%  
Depreciation Rs m3,0406,658 45.7%   
Interest Rs m52444,799 1.2%   
Profit before tax Rs m18,44318,567 99.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6405,108 32.1%   
Profit after tax Rs m16,80313,459 124.8%  
Gross profit margin %19.244.9 42.7%  
Effective tax rate %8.927.5 32.3%   
Net profit margin %15.89.6 164.3%  
BALANCE SHEET DATA
Current assets Rs m84,354251,882 33.5%   
Current liabilities Rs m48,053195,756 24.5%   
Net working cap to sales %34.140.1 85.1%  
Current ratio x1.81.3 136.4%  
Inventory Days Days421,969 2.1%  
Debtors Days Days654 1,529.6%  
Net fixed assets Rs m43,245816,105 5.3%   
Share capital Rs m239477 50.1%   
"Free" reserves Rs m86,134354,414 24.3%   
Net worth Rs m86,373354,891 24.3%   
Long term debt Rs m94437,784 0.0%   
Total assets Rs m127,5991,067,987 11.9%  
Interest coverage x36.21.4 2,560.5%   
Debt to equity ratio x01.2 0.1%  
Sales to assets ratio x0.80.1 636.1%   
Return on assets %13.65.5 248.9%  
Return on equity %19.53.8 513.0%  
Return on capital %21.98.0 274.4%  
Exports to sales %18.70-   
Imports to sales %00.2 0.0%   
Exports (fob) Rs m19,924NA-   
Imports (cif) Rs mNA302 0.0%   
Fx inflow Rs m19,9241,125 1,770.5%   
Fx outflow Rs m3,911302 1,297.0%   
Net fx Rs m16,013824 1,943.8%   
CASH FLOW
From Operations Rs m11,11087,496 12.7%  
From Investments Rs m-14,351-22,262 64.5%  
From Financial Activity Rs m3,796-69,880 -5.4%  
Net Cashflow Rs m5807,000 8.3%  

Share Holding

Indian Promoters % 57.2 43.5 131.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.2 39.9 50.6%  
FIIs % 4.5 32.1 13.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.8 56.5 75.8%  
Shareholders   79,721 259,635 30.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Piramal Enterprises

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Piramal Enterprises Share Price Performance

Period ALKEM LABORATORIES Piramal Enterprises S&P BSE HEALTHCARE
1-Day -0.45% -0.42% -0.10%
1-Month -6.02% 2.58% -1.99%
1-Year -10.25% -37.07% -5.62%
3-Year CAGR 15.27% -4.51% 20.96%
5-Year CAGR 9.10% -10.27% 11.47%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Piramal Enterprises share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.2% stake in the company. In case of Piramal Enterprises the stake stands at 43.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Piramal Enterprises.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

Piramal Enterprises paid Rs 33.0, and its dividend payout ratio stood at 58.5%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Piramal Enterprises.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.